metformin has been researched along with Aneurysm, Aortic in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin therapy has previously been associated with reduced abdominal aortic aneurysm growth rate in diabetic patients and shown to suppress the formation and progression of abdominal aortic aneurysm in normoglycemic mice." | 8.12 | Metformin therapy is not associated with the lower prevalence of ascending aortic aneurysm in diabetic patients. ( Björck, HM; Franco-Cereceda, A; Ntika, S; Olsson, C; Vignac, M, 2022) |
| "Metformin therapy has previously been associated with reduced abdominal aortic aneurysm growth rate in diabetic patients and shown to suppress the formation and progression of abdominal aortic aneurysm in normoglycemic mice." | 4.12 | Metformin therapy is not associated with the lower prevalence of ascending aortic aneurysm in diabetic patients. ( Björck, HM; Franco-Cereceda, A; Ntika, S; Olsson, C; Vignac, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vignac, M | 1 |
| Ntika, S | 1 |
| Olsson, C | 1 |
| Franco-Cereceda, A | 1 |
| Björck, HM | 1 |
1 other study available for metformin and Aneurysm, Aortic
| Article | Year |
|---|---|
Metformin therapy is not associated with the lower prevalence of ascending aortic aneurysm in diabetic patients.
Topics: Animals; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Aortic Valve; Diabetes Mellitus; Humans; Metfo | 2022 |